ZYBT · NASDAQ
Zhengye Biotechnology Holding (ZYBT) Stock Price & Fundamentals
Zhengye Biotechnology Holding (ZYBT) closed at $1,063.75 on Oct 9, 2026, up 0.22% from the previous close of $1,061.46.
Share price, past year
1Y +37.91%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $1,063.75 |
| Sep 30, 2026 | $1,006.91 |
| Aug 31, 2026 | $1,008.41 |
| Jul 31, 2026 | $1,020.66 |
| Jun 30, 2026 | $945.78 |
| May 29, 2026 | $925.17 |
| Apr 30, 2026 | $879.17 |
| Mar 31, 2026 | $865.64 |
| Feb 27, 2026 | $878.90 |
| Jan 30, 2026 | $865.07 |
| Dec 31, 2025 | $883.86 |
| Nov 28, 2025 | $836.73 |
| Oct 31, 2025 | $804.04 |
Key statistics
- Market cap
- $50.41B
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- —
- Shares outstanding
- 47.4M
- Dividend yield
- —
- 52-week range
- $767.15 – $1,063.75
Zhengye Biotechnology Holding's market cap is $50.41B, based on a share price of $1,063.75 and 47.4M shares outstanding as of Dec 31, 2025.
Financials
Zhengye Biotechnology Holding reported revenue of $16.64M for fiscal 2025, down 34.83% from fiscal 2024.
Zhengye Biotechnology Holding reported a net loss of $9.98M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $16.64M | −34.8% | −$9.98M | −60.0% | — | $1.77M |
| FY2024ended Dec 31, 2024 | $25.53M | — | $1.55M | 6.1% | $0.03 | $3.76M |
Company profile
- Name
- Zhengye Biotechnology Holding Ltd
- Ticker
- ZYBT
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- No.1 Lianmeng Street, Jilin Economic &, Technical Development Zone, Jilin
- Incorporated in
- F4
- SEC CIK
- 0001975641
Frequently asked questions
What is Zhengye Biotechnology Holding's stock price?
Zhengye Biotechnology Holding (ZYBT) closed at $1,063.75 on Oct 9, 2026, up 0.22% from the previous close of $1,061.46.
What is Zhengye Biotechnology Holding's market cap?
Zhengye Biotechnology Holding's market cap is $50.41B, based on a share price of $1,063.75 and 47.4M shares outstanding as of Dec 31, 2025.
How much revenue does Zhengye Biotechnology Holding make?
Zhengye Biotechnology Holding reported revenue of $16.64M for fiscal 2025, down 34.83% from fiscal 2024.
Sources and methodology
Fundamentals come from Zhengye Biotechnology Holding Ltd's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures